Role of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core

被引:43
|
作者
Briones, Marisa S.
Dobard, Charles W.
Chow, Samson A.
机构
[1] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
TERMINAL CAPSID MUTANTS; CYCLOPHILIN-A; REVERSE TRANSCRIPTION; TRIM5-ALPHA RESTRICTION; HOST RESTRICTION; HIV-1; INFECTION; NUCLEAR IMPORT; MUTATIONS; PROTEIN; NEF;
D O I
10.1128/JVI.02382-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
After membrane fusion with a target cell, the core of human immunodeficiency virus type 1 (HIV-1) enters into the cytoplasm, where uncoating occurs. The cone-shaped core is composed of the viral capsid protein (CA), which disassembles during uncoating. The underlying factors and mechanisms governing uncoating are poorly understood. Several CA mutations can cause changes in core stability and a block at reverse transcription, demonstrating the requirement for optimal core stability during viral replication. HIV-1 integrase (IN) catalyzes the insertion of the viral cDNA into the host genome, and certain IN mutations are pleiotropic. Similar to some CA mutants, two IN mutants, one with a complete deletion of IN (NL-Delta IN) and the other with a Cys-to-Ser substitution (NL-C130S), were noninfectious, with a replication block at reverse transcription. Compared to the wild type (WT), the cytoplasmic CA levels of the IN mutants in infected cells were reduced, suggesting accelerated uncoating. The role of IN during uncoating was examined by isolating and characterizing cores from NL-Delta IN and NL-C130S. Both IN mutants could form functional cores, but the core yield and stability were decreased. Also, virion incorporation of cyclophilin A (CypA), a cellular peptidyl-prolyl isomerase that binds specifically to CA, was decreased in the IN mutants. Cores isolated from WT virus depleted of CypA had an unstable-core phenotype, confirming a role of CypA in promoting optimal core stability. Taken together, our results indicate that IN is required during uncoating for maintaining CypA-CA interaction, which promotes optimal stability of the viral core.
引用
收藏
页码:5181 / 5190
页数:10
相关论文
共 50 条
  • [21] Pharmacovirological Impact of an Integrase Inhibitor on Human Immunodeficiency Virus Type 1 cDNA Species In Vivo
    Goffinet, Christine
    Allespach, Ina
    Oberbremer, Lena
    Golden, Pamela L.
    Foster, Scott A.
    Johns, Brian A.
    Weatherhead, Jason G.
    Novick, Steven J.
    Chiswell, Karen E.
    Garvey, Edward P.
    Keppler, Oliver T.
    JOURNAL OF VIROLOGY, 2009, 83 (15) : 7706 - 7717
  • [22] Human Immunodeficiency Virus Type 1 Viral Load Testing in Developing Countries
    Kraft, Colleen S.
    Ramirez, Gina
    Caliendo, Angela M.
    POINT OF CARE, 2006, 5 (04): : 186 - 191
  • [23] Development and validation of a cell-based assay system to assess human immunodeficiency virus type 1 integrase multimerization
    Nakamura, Tomofumi
    Campbell, Joseph R.
    Moore, Amber R.
    Otsu, Sachiko
    Aikawa, Haruo
    Tamamura, Hirokazu
    Mitsuya, Hiroaki
    JOURNAL OF VIROLOGICAL METHODS, 2016, 236 : 196 - 206
  • [24] Human immunodeficiency virus type 1 Vpr: functions and molecular interactions
    Romani, Bizhan
    Engelbrecht, Susan
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 1795 - 1805
  • [25] Impairment of Human Immunodeficiency Virus Type-1 Integrase SUMOylation Correlates with an Early Replication Defect
    Zamborlini, Alessia
    Coiffic, Audrey
    Beauclair, Guillaume
    Delelis, Olivier
    Paris, Joris
    Koh, Yashuiro
    Magne, Fabian
    Giron, Marie-Lou
    Tobaly-Tapiero, Joelle
    Deprez, Eric
    Emiliani, Stephane
    Engelman, Alan
    de The, Hugues
    Saib, Ali
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (23) : 21013 - 21022
  • [26] A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes
    Van Baelen, Kurt
    Rondelez, Evelien
    Van Eygen, Veerle
    Arien, Kevin
    Clynhens, Marleen
    Van den Zegel, Peggy
    Winters, Bart
    Stuyver, Lieven J.
    JOURNAL OF VIROLOGICAL METHODS, 2009, 161 (02) : 231 - 239
  • [27] HLA-Associated Viral Mutations Are Common in Human Immunodeficiency Virus Type 1 Elite Controllers
    Miura, Toshiyuki
    Brumme, Chanson J.
    Brockman, Mark A.
    Brumme, Zabrina L.
    Pereyra, Florencia
    Block, Brian L.
    Trocha, Alicja
    John, Mina
    Mallal, Simon
    Harrigan, P. Richard
    Walker, Bruce D.
    JOURNAL OF VIROLOGY, 2009, 83 (07) : 3407 - 3412
  • [28] Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins
    Ng, TB
    Lam, TL
    Au, TK
    Ye, XY
    Wan, CC
    LIFE SCIENCES, 2001, 69 (19) : 2217 - 2223
  • [29] Human immunodeficiency virus type 1 divergent variants
    Plantier, J. -C.
    Simon, F.
    JOURNAL DES ANTI-INFECTIEUX, 2011, 13 (03) : 170 - 183
  • [30] Human immunodeficiency virus type 1 impairs sumoylation
    Mete, Bilgul
    Pekbilir, Emre
    Bilge, Bilge Nur
    Georgiadou, Panagiota
    Celik, Elif
    Sutlu, Tolga
    Tabak, Fehmi
    Sahin, Umut
    LIFE SCIENCE ALLIANCE, 2022, 5 (06)